A股異動丨城投控股連升8日 區間升幅達30% 股價創近4個月新高
城投控股(600649.SH)再度拉昇升超6%,8日連升達30%,股價重回4元關口創近4個月新高,市值站上百億元。公司日前公吿,子公司城投置地擬與浦江鎮人民政府和華漕鎮人民政府簽訂改造項目合作協議,並分別與浦江鎮和華漕鎮的集體經濟組織成立合資公司,投資建設閔行區浦江鎮杜行老街“城中村”改造項目和華漕鎮諸翟“城中村”改造項目。其中,杜行項目投資總額約為65.17億元,諸翟項目投資總額約為118.39億元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.